| Literature DB >> 16511611 |
Abstract
Fabry disease is an inherited enzyme deficiency of galactosidase A that results in various phenotypes: classic, cardiac or renal. It can present variably and may represent an important cause of occult neurological and cardiac syndromes and renal failure. Preclinical and clinical studies demonstrate effectiveness of enzyme infusion in controlling and preventing these manifestations of the disease. Copyright 2006 Prous ScienceEntities:
Mesh:
Substances:
Year: 2006 PMID: 16511611 DOI: 10.1358/dot.2006.42.1.957357
Source DB: PubMed Journal: Drugs Today (Barc) ISSN: 1699-3993 Impact factor: 2.245